Why Peptide Manufacturers Moved Into Oligonucleotides: Shared Solid-Phase Roots, Different Challenges
Introduction Contract development and manufacturing organizations (CDMOs) that initially specialized in synthetic peptides have expanded their capabilities into nucleic acid […]


